Springfield, NJ, United States of America

Rachel S Kohn


Average Co-Inventor Count = 1.2

ph-index = 8

Forward Citations = 243(Granted Patents)


Company Filing History:


Years Active: 1984-2002

Loading Chart...
27 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Rachel S. Kohn – Pioneer in Biodegradable Pharmaceutical Compositions

Introduction: Rachel S. Kohn, based in Springfield, NJ, is a prolific inventor with an impressive portfolio of 27 patents. Her work focuses on the development of innovative materials and methods specifically tailored for the pharmaceutical industry, leading to significant advancements in drug delivery systems.

Latest Patents: One of Rachel’s most notable recent patents is for "Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same." This patent outlines a new class of biodegradable pharmaceutical compositions that serve as sustained release medicamentous compositions. The innovative method described includes the dry mixing of pharmaceutically active molecules with biodegradable polymers, followed by melt extrusion to create solid solutions. These solutions are then pulverized into microparticles suitable for injectable formulations. For instance, her patented compositions utilize polylactide-co-glycolide combined with specific active ingredients, releasing medication at a controlled rate for days to weeks. The implications of her work extend to treating a variety of conditions, including psychoses, sleep disorders, and anxiety, showcasing her commitment to improving mental health treatments.

Career Highlights: Throughout her career, Rachel has contributed her expertise to major organizations such as Hoechst Celanese Corporation and Celanese GmbH. Her innovative work has not only yielded numerous patents but has also positioned her as a key figure in the development of sustainable pharmaceutical technologies.

Collaborations: Rachel has had fruitful collaborations with esteemed colleagues in her field, including Tai-Shung Chung and Frank J. Onorato. These partnerships have facilitated groundbreaking research and development, further enhancing the efficacy of the innovations she proposes.

Conclusion: Rachel S. Kohn’s contributions to the field of biodegradable pharmaceuticals demonstrate her dedication to innovation and improving patient care. With 27 patents and ongoing research, she continues to be a vital force in the realm of pharmaceutical inventions, paving the way for future breakthroughs in drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…